LLY

Eli Lilly andA

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Curated Events

Active

Recent Headlines

New

Curated events

Materiality

m&a

Source

External coverage

Decided

2026-09-05

Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases

Lilly’s planned acquisition of Merida Biosciences is a positive strategic read-through for LLY through potential autoimmune and allergy pipeline expansion, but deal terms and execution details are unavailable.

View event details10 more curated

Sentiment decomposition

+0.7

30-day score

Company-55%

Macro-30%

Pulse-15%

Weekly research-10-day

Company, Macro, and Pulse form the existing 30-day artifact blend. Weekly research is tracked separately for 10 days and can contribute at most 10% of the sentiment pillar when live mode is enabled.

Recent headlines

No supplemental ticker headlines stored yet

We are still collecting relevant articles for LLY. Curated events highlight the most material developments impacting this ticker right now.

Check curated events Open full news archive

As of 2026-05-31 • Updated scheduledSource: News desk